The Gut Microbiota and Its Connection to Neurological Disorders - summary of current knowledge
DOI:
https://doi.org/10.12775/JEHS.2024.65.55389Keywords
gut microbiome, microbiota, neurological disorders, microbiota-gut-brain axisAbstract
Introduction and Purpose: The gut microbiota plays a crucial role not only in absorption, metabolic, and immune processes but also increasingly in shaping behavior and is strongly linked to the gut-brain axis. Different sections of the digestive system, due to varying environmental conditions and physiological functions, have a unique microbiota composition, both quantitatively and qualitatively, including bacteria, fungi, and archaea. This study aims to review current scientific research on the impact of the gut microbiome on the gut-brain axis and to explore how this influence may affect neurological disorders.
Brief Description of the State of Knowledge: Dysbiosis in the digestive system leads to changes in the composition of the gut microbiome, which can significantly impact the development and progression of various mental health conditions, as indicated by numerous clinical studies examining the gut-brain axis correlation. The main challenge is the insufficient understanding of which microorganisms within the human microbiota have positive or negative effects on mental health. Therefore, further research is needed to better elucidate these mechanisms.
Summary: Neurological disorders are a common challenge in clinical practice. Evaluating gut microbiota and metabolic states may provide valuable diagnostic and therapeutic insights, potentially improving patients' quality of life.
Materials and Evidence: A literature review was conducted using the PubMed database.
References
Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome. 2019 Jun 13;7(1):91. doi: 10.1186/s40168-019-0704-8. PMID: 31196177; PMCID: PMC6567490.
Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev. 2022 Jan 19;35(1):e0033820. doi: 10.1128/CMR.00338-20. Epub 2022 Jan 5. PMID: 34985325; PMCID: PMC8729913.
Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018 Jun 13;361:k2179. doi: 10.1136/bmj.k2179. PMID: 29899036; PMCID: PMC6000740.
Cani PD, de Vos WM. Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front Microbiol. 2017 Sep 22;8:1765. doi: 10.3389/fmicb.2017.01765. PMID: 29018410; PMCID: PMC5614963.
Banerjee G, Papri SR, Satapathy SK, Banerjee P. Akkermansia muciniphila - A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease. Curr Pharm Biotechnol. 2024;25(4):426-433. doi: 10.2174/1389201025666230915103052. PMID: 37724669.
Wu W, Kaicen W, Bian X, Yang L, Ding S, Li Y, Li S, Zhuge A, Li L. Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids. Microb Biotechnol. 2023 Oct;16(10):1924-1939. doi: 10.1111/1751-7915.14293. Epub 2023 Jun 28. PMID: 37377410; PMCID: PMC10527187.
Chang CS, Kao CY. Current understanding of the gut microbiota shaping mechanisms. J Biomed Sci. 2019 Aug 21;26(1):59. doi: 10.1186/s12929-019-0554-5. PMID: 31434568; PMCID: PMC6702754.
Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut. 2020 Aug;69(8):1510-1519. doi: 10.1136/gutjnl-2019-320204. Epub 2020 May 14. PMID: 32409589; PMCID: PMC7398478.
Vandenplas Y, Carnielli VP, Ksiazyk J, Luna MS, Migacheva N, Mosselmans JM, Picaud JC, Possner M, Singhal A, Wabitsch M. Factors affecting early-life intestinal microbiota development. Nutrition. 2020 Oct;78:110812. doi: 10.1016/j.nut.2020.110812. Epub 2020 Mar 25. PMID: 32464473
Frost F. Einführung in das Mikrobiom [Introduction to the microbiome]. Inn Med (Heidelb). 2022 Oct;63(10):1015-1021. German. doi: 10.1007/s00108-022-01395-9. Epub 2022 Sep 2. PMID: 36053301.
Ling Z, Liu X, Cheng Y, Yan X, Wu S. Gut microbiota and aging. Crit Rev Food Sci Nutr. 2022;62(13):3509-3534. doi: 10.1080/10408398.2020.1867054. Epub 2020 Dec 30. PMID: 33377391.
Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O'Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019 Oct 1;99(4):1877-2013. doi: 10.1152/physrev.00018.2018. PMID: 31460832.
Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int J Mol Sci. 2022 Sep 24;23(19):11245. doi: 10.3390/ijms231911245. PMID: 36232548; PMCID: PMC9570195.
Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res. 2021 Oct;172:105840. doi: 10.1016/j.phrs.2021.105840. Epub 2021 Aug 24. PMID: 34450312.
Lee A, Lee JY, Jung SW, Shin SY, Ryu HS, Jang SH, Kwon JG, Kim YS. [Brain-Gut-Microbiota Axis]. Korean J Gastroenterol. 2023 Apr 25;81(4):145-153. Korean. doi: 10.4166/kjg.2023.028. PMID: 37096434.
Mayer EA, Nance K, Chen S. The Gut-Brain Axis. Annu Rev Med. 2022 Jan 27;73:439-453. doi: 10.1146/annurev-med-042320-014032. Epub 2021 Oct 20. PMID: 34669431.
Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, Foo JB, Ong YS, How CW, Khaw KY. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther. 2024 Feb 16;9(1):37. doi: 10.1038/s41392-024-01743-1. PMID: 38360862; PMCID: PMC10869798.
Wang Q, Yang Q, Liu X. The microbiota-gut-brain axis and neurodevelopmental disorders. Protein Cell. 2023 Oct 25;14(10):762-775. doi: 10.1093/procel/pwad026. PMID: 37166201; PMCID: PMC10599644.
Wang Z, Wang Z, Lu T, Chen W, Yan W, Yuan K, Shi L, Liu X, Zhou X, Shi J, Vitiello MV, Han Y, Lu L. The microbiota-gut-brain axis in sleep disorders. Sleep Med Rev. 2022 Oct;65:101691. doi: 10.1016/j.smrv.2022.101691. Epub 2022 Aug 31. PMID: 36099873.
Taylor AM, Holscher HD. A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci. 2020 Mar;23(3):237-250. doi: 10.1080/1028415X.2018.1493808. Epub 2018 Jul 9. PMID: 29985786.
Redondo-Useros N, Nova E, González-Zancada N, Díaz LE, Gómez-Martínez S, Marcos A. Microbiota and Lifestyle: A Special Focus on Diet. Nutrients. 2020 Jun 15;12(6):1776. doi: 10.3390/nu12061776. PMID: 32549225; PMCID: PMC7353459.
Tanes C, Bittinger K, Gao Y, Friedman ES, Nessel L, Paladhi UR, Chau L, Panfen E, Fischbach MA, Braun J, Xavier RJ, Clish CB, Li H, Bushman FD, Lewis JD, Wu GD. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe. 2021 Mar 10;29(3):394-407.e5. doi: 10.1016/j.chom.2020.12.012. Epub 2021 Jan 12. PMID: 33440171; PMCID: PMC8022197.
Cryan JF, O'Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol. 2020 Feb;19(2):179-194. doi: 10.1016/S1474-4422(19)30356-4. Epub 2019 Nov 18. PMID: 31753762.
O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185-204. doi: 10.1146/annurev-neuro-061010-113613. PMID: 21456963; PMCID: PMC3174086.
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. Alzheimer's disease. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. PMID: 23225010.
Megur A, Baltriukienė D, Bukelskienė V, Burokas A. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame? Nutrients. 2020 Dec 24;13(1):37. doi: 10.3390/nu13010037. PMID: 33374235; PMCID: PMC7824474.
Baird G, Cass H, Slonims V. Diagnosis of autism. BMJ. 2003 Aug 30;327(7413):488-93. doi: 10.1136/bmj.327.7413.488. PMID: 12946972; PMCID: PMC188387.
Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014 Mar 8;383(9920):896-910. doi: 10.1016/S0140-6736(13)61539-1. Epub 2013 Sep 26. PMID: 24074734.
Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A. Gut microbiota in autism and mood disorders. World J Gastroenterol. 2016 Jan 7;22(1):361-8. doi: 10.3748/wjg.v22.i1.361. PMID: 26755882; PMCID: PMC4698498.
Beitz JM. Parkinson's disease: a review. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. PMID: 24389262.
Hayes MT. Parkinson's Disease and Parkinsonism. Am J Med. 2019 Jul;132(7):802-807. doi: 10.1016/j.amjmed.2019.03.001. Epub 2019 Mar 16. PMID: 30890425.
Bastos F, Cross JH. Epilepsy. Handb Clin Neurol. 2020;174:137-158. doi: 10.1016/B978-0-444-64148-9.00011-9. PMID: 32977874.
Dahlin M, Prast-Nielsen S. The gut microbiome and epilepsy. EBioMedicine. 2019 Jun;44:741-746. doi: 10.1016/j.ebiom.2019.05.024. Epub 2019 May 31. PMID: 31160269; PMCID: PMC6604367.
Arulsamy A, Shaikh MF. Epilepsy-associated comorbidities among adults: A plausible therapeutic role of gut microbiota. Neurobiol Dis. 2022 Apr;165:105648. doi: 10.1016/j.nbd.2022.105648. Epub 2022 Feb 1. PMID: 35121147.
Gómez-Eguílaz M, Ramón-Trapero JL, Pérez-Martínez L, Blanco JR. The beneficial effect of probiotics as a supplementary treatment in drug-resistant epilepsy: a pilot study. Benef Microbes. 2018 Dec 7;9(6):875-881. doi: 10.3920/BM2018.0018. Epub 2018 Sep 10. PMID: 30198325.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Oliwia Sysło, Magdalena Jung, Maximilian Jung, Barbara Sławińska, Aleksander Jaworski , Weronika Goliat, Konrad Haraziński, Maciej Rzepka, Magdalena Nalepa, Piotr Gutowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 92
Number of citations: 0